# US 2026/0083592 A1 · Eye Shunt System and Methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083592 A1
- Document ID: US20260083592A1
- Status: Published application
- Kind: A1
- Application number: 19/404,767
- Filed: 2025-12-01
- Published: 2026-03-26
- Earliest claimed: 2020-06-04
- Assignees: The United States Government as represented by the Department of Veterans Affairs; Board of Regents, The University of Texas System
- Applicants: United States Government as represented by the Department of Veterans Affairs; The Board of Regents of The University of Texas System
- Inventors: Karanjit S. Kooner; Michael A. Mong; Ghadeer Al-Humimat; Jacob A. Awkal; Hebah G. Abdallah; Nguyen L. Le; Jamasp Azamoosh; Peter Dirk Jan Reyntjens; Jeremy L. Warren
- Web page: https://patentgrep.com/patent/US20260083592A1

## CPC

- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A shunt operable to be implanted on an eye is provided. The shunt includes a vein fluidic channel operable to be in fluid communication with an interior of the eye and operable to receive aqueous fluid from the interior of the eye. A body is fluidly coupled with the vein fluidic channel. A valve is disposed within the body and is operable to regulate intraocular pressure in the eye by opening and closing based on pressure from the aqueous fluid. A plurality of outlets are in fluid communication with the body opposite the vein fluidic channel in relation to the valve. The outlets are operable to release the aqueous fluid to the sclera of the eye.

## Claims

### Claim 1

A shunt operable to be implanted on an eye, the shunt comprising:
a vein fluidic channel operable to be in fluid communication with an interior of the eye and operable to receive aqueous fluid from the interior of the eye;
a body fluidly coupled with the vein fluidic channel;
a valve disposed within the body, the valve operable to regulate intraocular pressure (IOP) in the eye by opening and closing based on pressure from the aqueous fluid; and
a plurality of outlets in fluid communication with the body opposite the vein fluidic channel in relation to the valve, the plurality of outlets operable to release the aqueous fluid to a sclera of the eye.

### Claim 2 (depends on 1)

The shunt of claim 1, wherein the plurality of outlets are operable to release the aqueous fluid at least 10 millimeters from a cornea of the eye.

### Claim 3 (depends on 1)

The shunt of claim 1, wherein the valve includes two leaflets, at least a portion of the two leaflets abutting one another when the valve is closed.

### Claim 4 (depends on 3)

The shunt of claim 3, wherein each of the two leaflets have a length that is two times a width of an inner lumen of the body.

### Claim 5 (depends on 3)

The shunt of claim 3, wherein, a base of each of the leaflets has a base thickness, and a thickness of the two leaflets tapers towards an end opposite the base.

### Claim 6 (depends on 5)

The shunt of claim 5, wherein the end opposite the base of each of the leaflets has an end thickness that is ⅓ the base thickness.

### Claim 7 (depends on 3)

The shunt of claim 3, wherein the two leaflets are operable to deform and separate from one another upon exposure to a predetermined amount of pressure from the aqueous fluid.

### Claim 8 (depends on 1)

The shunt of claim 1, wherein at least one of the vein fluidic channel, the body, the valve, and/or the plurality of outlets is at least partially coated with at least one drug to be released into the aqueous fluid.

### Claim 9 (depends on 8)

The shunt of claim 8, wherein the drug includes mitomycin-C.

### Claim 10 (depends on 8)

The shunt of claim 8, wherein the drug is configured to be released over a predetermined period of time.

### Claim 11 (depends on 10)

The shunt of claim 10, wherein the predetermined period of time is up to four weeks.

### Claim 12 (depends on 1)

The shunt of claim 1, further comprising: at least two retainers extending from the vein fluidic channel, the at least two retainers operable to maintain positioning of the vein fluidic channel.

### Claim 13 (depends on 12)

The shunt of claim 12, wherein the at least two retainers are substantially circular and extend radially from the vein fluidic channel.

### Claim 14 (depends on 12)

The shunt of claim 12, wherein the at least two retainers are positioned such that, when implanted, a first one of the at least two retainers is operable to be positioned on a trabecular meshwork surface of the eye and a second one of the at least two retainers is operable to be positioned on a scleral surface of the eye.

### Claim 15 (depends on 1)

The shunt of claim 1, wherein a surface of at least one of the vein fluidic channel, the body, and/or the plurality of outlets operable to be placed, when implanted, on the eye is flat.

### Claim 16 (depends on 1)

The shunt of claim 1, wherein at least one of the vein fluidic channel, the body, the valve, and/or the plurality of outlets is made of a bio-compatible material.

### Claim 17 (depends on 16)

The shunt of claim 16, wherein the bio-compatible material includes a hydrogel.

### Claim 18 (depends on 16)

The shunt of claim 16, wherein the bio-compatible material includes an acrylic hydrogel or a silicone hydrogel.

### Claim 19 (depends on 1)

A system comprising:
the shunt as recited in claim 1; and
a forceps operable to implant the shunt in the eye.

### Claim 20 (depends on 19)

The system of claim 19, wherein the forceps include tips collectively forming a hollow body operable to receive, when the tips are in a closed configuration, the vein fluidic channel.
